HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing could facilitate the choice of initial ART in are...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Rhee, Soo-Yon, Jordan, Michael R., Raizes, Elliot, Chua, Arlene, Parkin, Neil, Kantor, Rami, Van Zyl, Gert U., Mukui, Irene, Hosseinipour, Mina C., Frenkel, Lisa M., Ndembi, Nicaise, Hamers, Raph L., Rinke de Wit, Tobias F., Wallis, Carole L., Gupta, Ravindra K., Fokam, Joseph, Zeh, Clement, Schapiro, Jonathan M., Carmona, Sergio, Katzenstein, David, Tang, Michele, Aghokeng, Avelin F., De Oliveira, Tulio, Wensing, Annemarie M. J., Gallant, Joel E., Wainberg, Mark A., Richman, Douglas D., Fitzgibbon, Joseph E., Schito, Marco, Bertagnolio, Silvia, Yang, Chunfu, Shafer, Robert W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696791/
https://ncbi.nlm.nih.gov/pubmed/26717411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0145772
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi